[Duodenal ulcer. Randomized study with 8 therapeutic schedules]

Area of Science:

• Gastroenterology
• Pharmacology

Background:

• Duodenal ulcers are common gastrointestinal conditions requiring effective outpatient management.
• Several drug regimens combining anticholinergics, sulphoglicopeptide, and sucralfate have been proposed for treatment.

Purpose of the Study:

• To evaluate the efficacy of 8 therapeutic regimens, including drug combinations, compared to placebo for duodenal ulcer healing.
• To determine if specific drug combinations offer statistically significant improvement over placebo.

Main Methods:

• A randomized study involving 112 outpatients with duodenal ulcers.
• Testing of 8 therapeutic regimens, including combinations of anticholinergics, sulphoglicopeptide, and sucralfate, against a placebo.
• A 30-month follow-up period to assess healing rates.

Main Results:

• No tested therapeutic regimen demonstrated statistically significant improvement in duodenal ulcer healing rates compared to placebo.
• The most effective regimen (anticholinergic plus sucralfate) achieved a 64.2% healing rate, while placebo achieved 42.8%.
• Combined drug regimens showed a 44.6% healing rate within 60 days, not significantly better than placebo.

Conclusions:

• Current therapeutic regimens combining anticholinergics, sulphoglicopeptide, and sucralfate do not offer statistically significant advantages over placebo for duodenal ulcer management.
• Further research is needed to identify more effective treatments for duodenal ulcers.